MedTrace Logo

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

NCT04156464 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2020-10-08

No results posted yet for this study

Summary

Our aim is to compare outcomes of patients with benzodiazepine-refractory alcohol withdrawal syndrome who are treated with either a phenobarbital-based or a lorazepam based protocol.

Conditions

  • Alcohol Withdrawal
  • Alcohol Withdrawal Delirium

Interventions

DRUG

Phenobarbital

Phenobarbital loading dose followed by a taper will be given to control acute alcohol withdrawal syndrome

DRUG

Lorazepam

Ativan will be given according to our institutional alcohol withdrawal protocol to control acute alcohol withdrawal syndrome

Sponsors & Collaborators

  • OSF Healthcare System

    lead OTHER

Principal Investigators

  • Bhagat Aulakh, MD · OSF Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2021-12-01
Completion
2022-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04156464 on ClinicalTrials.gov